Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)
Public ClinicalTrials.gov record NCT02914639. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study was to evaluate the safety and exploratory efficacy of SF0166 Topical Ophthalmic Solution in patients with Neovascular (wet) Age-related Macular Degeneration (AMD).
Study identification
- NCT ID
- NCT02914639
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 44 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 5, 2016 (Actual)
- Primary completion
- Jun 26, 2017 (Actual)
- Completion
- Jun 26, 2017 (Actual)
- Last update posted
- Jun 7, 2023
2016 – 2017
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retinal Research Institute LLC | Phoenix | Arizona | 85014 | — |
| Retina Consultants of Orange County | Fullerton | California | 92861 | — |
| Northern California Retina Vitreous Associates Medical Group, Inc | Mountain View | California | 94040 | — |
| Retina Macula Specialists of Miami, LLC | Miami | Florida | 33126 | — |
| Center for Retina and Macular Disease | Winter Haven | Florida | 33880 | — |
| John Kenyon Eye Institute | New Albany | Indiana | 47150 | — |
| Ophthalmic Consultants of Boston | Boston | Massachusetts | 02114 | — |
| Black Hills Regional Eye Institute | Rapid City | South Dakota | 57701 | — |
| West Texas Retina Consultants | Abilene | Texas | 79606 | — |
| Retina Research Center, PLLC | Austin | Texas | 78705 | — |
| Texas Retina Associates | Fort Worth | Texas | 76104 | — |
| Spokane Eye Clinical Research | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02914639, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 7, 2023 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02914639 live on ClinicalTrials.gov.